Former FDA Cancer Drug Chief Under Consideration to Return
Source: Bloomberg
June 27, 2026 at 3:28 PM EDT
Richard Pazdur, an oncologist who spent 26 years at the US Food and Drug Administration before his abrupt exit in December, is under consideration to return to the agency, people familiar with the matter said.
Pazdur left the FDA just weeks after he was promoted to be the agency’s top drug regulator. The drug industry and its investors viewed Pazdur as a steady hand at the FDA and a return could signal an attempt to stabilize the regulator rocked by months of turmoil.
He is being considered for a senior leadership role, according to the people, who spoke on condition of anonymity because the discussions are confidential.
The administration plans to announce a senior leadership team alongside the commissioner nominee, the people said. The discussions are still underway and no decisions have been made, they added.
Read more: https://www.bloomberg.com/news/articles/2026-06-27/former-fda-cancer-drug-chief-under-consideration-to-return?srnd=homepage-americas
No paywall (gift)